Incyte Corp. (INCY) stock forecast and price target
Price $120.97 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($120.97)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $3.46 | −49.1% | $6.1B |
| Next fiscal year ends December 31, 2027 | $8.64 | +149.7% | $6.3B |
| Next quarter ends December 31, 2026 | $1.97 | +9.6% | $1.6B |
| Quarter after ends March 31, 2027 | $1.72 | −5.2% | $1.4B |
Consensus of the analysts covering Incyte, updated daily. In the last 30 days 8 estimates were raised and 7 lowered.
Our model vs. Wall Street
Analysts see 9.3% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Incyte’s intrinsic value about 48% below today’s market value, and it scores 2.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Incyte stock price target?
The average 12-month target from 24 analysts is $132.25, 9.3% above the current price of $120.97 Targets range from $100.00 to $157.00.
Is Incyte a buy according to analysts?
The consensus rating is “Buy” (2 strong buy, 11 buy, 14 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.
How much is Incyte expected to earn?
Analysts expect EPS of $3.46 for the fiscal year ending December 31, 2026 and $8.64 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.